Molecular pathways: Jak/STAT pathway: mutations, inhibitors, and resistance.


Aberrant activation of the JAK/STAT pathway has been reported in a variety of disease states, including inflammatory conditions, hematologic malignancies, and solid tumors. For instance, a large proportion of patients with myeloproliferative neoplasms (MPN) carry the acquired gain-of-function JAK2 V617F somatic mutation. This knowledge has dramatically… (More)
DOI: 10.1158/1078-0432.CCR-12-0284


2 Figures and Tables

Slides referencing similar topics